BridgeMD
New treatment option for Non Hodgkin Lymphoma
Official title Lifestyle Intervention of Food and Exercise for Lymphoma Survivors
ClinicalTrials.gov ID: NCT05839210
What this study is testing
- What it's testing
- The purpose of this study is to investigate if a mediterranean diet and exercise program for Lymphoma patients during chemotherapy can improve treatment completion and reduce treatment-related side effects.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years of age or older
- Any sex/gender
- Able to provide consent
- Able to read or understand English or Spanish
- Diagnosis of untreated Non-Hodgkin or Hodgkin lymphoma, requiring at least 6 cycles of chemotherapy, being treated with one of the following...
You likely can't join if
- Individuals younger than 18 years of age
- Unable to provide consent
- Unable to read or understand English or Spanish
- Any contraindication for diet change or exercising as determined by physician
- Currently following a vegan or ketogenic diet, or consuming more than 5 servings of fruit and vegetables per day for the prior month
- Engaging in \>150 minutes of moderate to vigorous physical activity on average per week for the prior month
See the full eligibility criteria
- 18 years of age or older
- Any sex/gender
- Able to provide consent
- Able to read or understand English or Spanish
- Diagnosis of untreated Non-Hodgkin or Hodgkin lymphoma, requiring at least 6 cycles of chemotherapy, being treated with one of the following therapies at discretion of PIs:
- R-CHOP or R-CHOP-like regimen
- BV-AVD or ABVD or checkpoint inhibitor+AVD
- ECOG Performance Status grade of \<2 a. PI approval needed if ECOG = 2
- Approval from treating oncologist, confirmed via email or in writing
- Delivery of chemotherapy treatments at one of the following institutions:
- Sylvester Comprehensive Cancer Center (including satellite/network sites)
- University of Miami Hospital/UHealth Tower
- Internet access on a smart phone, tablet, or computer
- Willing to be assigned by chance to a Mediterranean diet/home-based physical activity intervention or waitlist-control group.
- Individuals younger than 18 years of age
- Unable to provide consent
- Unable to read or understand English or Spanish
- Any contraindication for diet change or exercising as determined by physician
- Currently following a vegan or ketogenic diet, or consuming more than 5 servings of fruit and vegetables per day for the prior month
- Engaging in \>150 minutes of moderate to vigorous physical activity on average per week for the prior month
- History of dementia or major psychiatric disease
- History of recent (≤1 yr) stroke, myocardial infarction or congestive heart failure
The study team makes the final eligibility decision.
Where it's taking place
- Miami, Florida, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Miami, Florida, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.